E-LIB Suche - Ergebnisse für: Bijou, Fontanet - Sprache DE

Personensuche X

Sortierung: Relevanz

Sortierung: Jahr

1

Cerebellum/liver index on baseline 18F-FDG PET/CT to improv..:

Morland, David ; Kanagaratnam, Lukshe ; Hubelé, Fabrice...
EJNMMI Research. 14 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Final results on effectiveness and safety of Ibrutinib in p..:

Dartigeas, Caroline ; Quinquenel, Anne ; Ysebaert, Loïc...
Annals of Hematology. , 2024

Link: https://doi.org/10.1007/..

3

Challenges for quality and utilization of real-world data f..:

Ghesquières, Hervé ; Cherblanc, Fanny ; Belot, Aurélien...
Blood Advances. 8 (2024) 2 - p. 296-308 , 2024

Link: https://doi.org/10.1182/..

4

S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL A..:

Chatzikonstantinou, Thomas ; Scarfò, Lydia ; Karakatsoulis, Georgios...
HemaSphere. 7 (2023) S3 - p. e24596f8 , 2023

Link: https://doi.org/10.1097/..

5

Other malignancies in the history of CLL: an international ..:

Chatzikonstantinou, Thomas ; Scarfò, Lydia ; Karakatsoulis, Georgios...
eClinicalMedicine. 65 (2023) - p. 102307 , 2023

Link: https://doi.org/10.1016/..

6

Long-Term Efficacy and Safety of Zanubrutinib in Patients w..:

Opat, Stephen ; Tedeschi, Alessandra ; Hu, Bei...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S105-S106 , 2023

Link: https://doi.org/10.1016/..

7

Salvage therapy with brentuximab-vedotin and bendamustine f..:

Aubrais, Raphaelle ; Bouabdallah, Krimo ; Chartier, Loic...
Blood Advances. 7 (2023) 19 - p. 5733-5742 , 2023

Link: https://doi.org/10.1182/..

8

P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB I..:

Trotman, Judith ; Luigi Zinzani, Pier ; Mayer, Jiri...
HemaSphere. 7 (2023) S3 - p. e2687131 , 2023

Link: https://doi.org/10.1097/..

9

Safety and efficacy of zanubrutinib in relapsed/refractory ..:

Opat, Stephen ; Tedeschi, Alessandra ; Hu, Bei...
Blood Advances. 7 (2023) 22 - p. 6801-6811 , 2023

Link: https://doi.org/10.1182/..

10

Baseline 18F-FDG Metabolic Tumor Volume Predicts Response t..:

Morland, David ; Kanagaratnam, Lukshe ; Hubelé, Fabrice...
HemaSphere. 7 (2023) 2 - p. e833 , 2023

Link: https://doi.org/10.1097/..

11

Deciphering Genetic Alterations of Hairy Cell Leukemia and ..:

Maitre, Elsa ; Tomowiak, Cécile ; Lebecque, Benjamin...
Cancers. 14 (2022) 8 - p. 1904 , 2022

Link: https://doi.org/10.3390/..

12

Does early disease progression predict survival after first..:

Labreuche, Julien ; Assouan, Deborah ; Durot, Eric...
Hematological Oncology. 40 (2022) 3 - p. 400-408 , 2022

Link: https://doi.org/10.1002/..

13

Phase Ib study of avadomide (CC‐122) in combination with ri..:

Nastoupil, Loretta J. ; Kuruvilla, John ; Chavez, Julio C....
eJHaem. 3 (2022) 2 - p. 394-405 , 2022

Link: https://doi.org/10.1002/..

14

A French multicentric prospective prognostic cohort with ep..:

Ghesquières, Hervé ; Rossi, Cédric ; Cherblanc, Fanny...
BMC Public Health. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

15

Relevance of treatment‐free remission recommendations in ch..:

Etienne, Gabriel ; Faberes, Carole ; Bauduer, Fréderic...
Cancer Medicine. 10 (2021) 11 - p. 3635-3645 , 2021

Link: https://doi.org/10.1002/..

1-15